These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 32272891)
1. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis. Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891 [TBL] [Abstract][Full Text] [Related]
2. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population. Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090 [TBL] [Abstract][Full Text] [Related]
3. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES. Simon TG; Bonilla H; Yan P; Chung RT; Butt AA Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205 [TBL] [Abstract][Full Text] [Related]
4. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study. Chang FM; Wang YP; Lang HC; Tsai CF; Hou MC; Lee FY; Lu CL Hepatology; 2017 Sep; 66(3):896-907. PubMed ID: 28318053 [TBL] [Abstract][Full Text] [Related]
5. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128 [TBL] [Abstract][Full Text] [Related]
6. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS; Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403 [TBL] [Abstract][Full Text] [Related]
7. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma? Lok AS J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361 [TBL] [Abstract][Full Text] [Related]
8. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882 [TBL] [Abstract][Full Text] [Related]
9. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis. Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293 [TBL] [Abstract][Full Text] [Related]
10. Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis. Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y Medicine (Baltimore); 2018 Aug; 97(34):e11950. PubMed ID: 30142817 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection. Aljumah AA; Kuriry H; Faisal N; Alghamdi H Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991 [TBL] [Abstract][Full Text] [Related]
12. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis. Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777 [TBL] [Abstract][Full Text] [Related]
13. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. Lu T; Seto WK; Zhu RX; Lai CL; Yuen MF World J Gastroenterol; 2013 Dec; 19(47):8887-94. PubMed ID: 24379612 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic viruses and hepatocellular carcinoma. Ben Ari Z; Weitzman E; Safran M Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667 [TBL] [Abstract][Full Text] [Related]
16. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Chen CL; Yang HI; Yang WS; Liu CJ; Chen PJ; You SL; Wang LY; Sun CA; Lu SN; Chen DS; Chen CJ Gastroenterology; 2008 Jul; 135(1):111-21. PubMed ID: 18505690 [TBL] [Abstract][Full Text] [Related]
17. Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis. Li X; Liu L; Hu Y Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32162652 [TBL] [Abstract][Full Text] [Related]
18. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis. Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695 [TBL] [Abstract][Full Text] [Related]
19. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. Tsan YT; Lee CH; Wang JD; Chen PC J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485 [TBL] [Abstract][Full Text] [Related]
20. Statin-Based Palliative Therapy for Hepatocellular Carcinoma. Shao JY; Lee FP; Chang CL; Wu SY Medicine (Baltimore); 2015 Oct; 94(42):e1801. PubMed ID: 26496314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]